Category Archives: Guest Blog

EMA Responds Robustly to Conflict-of-Interest Claims

By Philip Ward, Applied Clinical Trials. The European Medicines Agency (EMA) has insisted that the concerns raised about its scientific advice given to pharmaceutical companies stem from a flawed understanding of the activities of the agency and its partners in this area.
Also posted in Europe, Global, Regulatory | Tagged , , , , , | Leave a comment

CMOs Take a Hit as Payers Refuse to Cover New Drugs

By Jim Miller. The value of the customer relationship to a CMO is a function of two variables: unit volume and price per unit. Both variables are contentious issues: bio/pharmaceutical companies are putting enormous pressure on their CMOs for lower prices, while their inability to deliver forecasted volumes often means lost revenues for CMOs as […]
Also posted in Europe, Global, pricing | Tagged , , , | Leave a comment

Pharma Report Predicts Trillion Dollar Global Industry by 2020

By Colin McMahon. EvalutePharma’s seventh edition of its World Preview documents that worldwide prescription drug sales forecast will exceed the one trillion dollar mark by 2020. The company bases this estimate on the growing compound annual growth rate (CAGR) that the pharmaceutical industry is currently enjoying. It predicts that CAGR will continue to grow through […]
Also posted in FDA, Gene therapy, Global, R&D, Strategy | Tagged , , | Leave a comment

The Technologies Set to Transform Healthcare

By G. Steven Burrill, CEO, Burrill & Company. The promise of precision medicine is beginning to bear fruit as deadly diseases are made treatable, doctors use genetic information to guide treatment decisions, and the convergence of information, communications, and biological technology reinvents the practice of medicine. The arrival of this new age of medicine has […]
Also posted in Biotech, Global, healthcare, Op-Ed, Technology | Tagged , , , | Leave a comment

What Drives Patient Interest in Clinical Trials?

By Fred Gebhart. Recruiting patients remains one of the most difficult challenges clinical trial sponsors face. Recognizing that fewer than five percent of eligible adult patients enroll in therapeutic trials, many sponsors have turned to supplemental recruitment, the practice of pre-qualifying community-based patients for referral to clinical trial sites for screening. “The primary reason that […]
Also posted in patient education, R&D | Tagged , | Leave a comment
  • Categories

  • Meta